AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
For Birkenstock, the long-term case still hinges on believing in the durability of its brand and the company’s ability to convert that into steady, profitable growth, even if near-term earnings are a bit bumpy. The latest quarter showed higher sales but softer profit, and management’s move to raise 2026 revenue growth guidance to 15% sits in tension with a share price that has fallen more than 30% over the past year. The paired US$1.00 billion follow-on offering and US$500 million buyback at US$39.18 effectively recycle stock from existing holders and modestly tighten the float, but they do not change the core operational catalysts: execution in direct-to-consumer, pricing power, and brand momentum. Near term, the bigger swing factors remain margin pressure and any impact from insider selling and lock-up expiries.
However, investors should also be aware of how margin pressure could interact with the new capital structure. Despite retreating, Birkenstock Holding's shares might still be trading 36% above their fair value. Discover the potential downside here.Six fair value estimates from the Simply Wall St Community span roughly US$43 to almost US$68 per share, underlining how far apart individual views sit. Set against Birkenstock’s recent guidance upgrade and ongoing margin pressures, this spread shows why it can pay to weigh several perspectives before deciding how the current share price lines up with the company’s execution risks and potential.
Explore 6 other fair value estimates on Birkenstock Holding - why the stock might be worth just $43.11!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com